Bausch & Lomb Corp (BLCO): Capital Expenditures
$349.00M
Year ended 2025-12-31
$321.00M
Trailing 12 months to 2026-06-30
+25.9%
3-year compound annual growth
+6.6%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $349.00M | +19.9% | 2026-02-18, From 2025-01-01 |
| 2024-12-31 | $291.00M | +60.8% | 2026-02-18, From 2024-01-01 |
| 2023-12-31 | $181.00M | +3.4% | 2026-02-18, From 2023-01-01 |
| 2022-12-31 | $175.00M | -9.3% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | $193.00M | -23.7% | 2024-02-21, From 2021-01-01 |
| 2020-12-31 | $253.00M | n/a | 2023-02-22, From 2020-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Bausch & Lomb Corp (BLCO) | 2025-12-31 | $349.00M | +19.9% |
| Cooper Companies, Inc. (COO) | 2025-10-31 | $362.40M | -14.0% |
| National Vision Holdings, Inc. (EYE) | 2026-01-03 | $72.84M | -23.7% |
| Warby Parker Inc. (WRBY) | 2025-12-31 | $67.05M | +4.7% |
| Staar Surgical Co (STAA) | 2026-01-02 | $5.82M | -75.1% |
| RxSight, Inc. (RXST) | 2025-12-31 | $3.83M | -29.6% |
| Innovative Eyewear Inc (LUCYW) | 2025-12-31 | $72.5K | +16.6% |
Compare BLCO, COO, EYE, WRBY side by side · Screen every company in Ophthalmic Goods ↗